Authors:
Chad Cherington, MD, Alan Bryce, MD, David Arguello, MD, Sherri Z. Millis, PhD, Ryan Bender, PhD, Sandeep Reddy, MD, Zoran Gatalica, MD/PhD, Rene Gonzalez, MD
background
Mucosal melanoma is a rare malignancy, notoriously resistant to conventional chemotherapy, with few treatment options. Because of their origin, they do not receive screening and, hence, are
detected in advanced stages where prognosis and curative rates are poor. The purpose of this study is to identify novel, potential targets and therapeutic options for this disease, utilizing a multiplatform approach.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |